Mesoblast Appoints Bill Burns, Former Chief Executive of Roche Pharmaceuticals, as Vice Chairman
Sep 01, 2016 10:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, Sept. 01, 2016 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that Mr William (Bill) A. Burns, former Chief Executive Officer (CEO) of Roche Pharmaceuticals, has been...
Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference
Sep 01, 2016 10:00 am UTC| Business
RANCHO CUCAMONGA, Calif., Sept. 01, 2016 -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Wells Fargo Healthcare Conference on Thursday,...
Glacier Bancorp, Inc. Completes Acquisition of Treasure State Bank in Missoula, Montana
Sep 01, 2016 10:00 am UTC| Business
KALISPELL, Mont., Sept. 01, 2016 -- Glacier Bancorp, Inc. (NASDAQ:GBCI) today announced the completion of its acquisition of Treasure State Bank (OTC Pink:TRSU), a community bank based in Missoula, Montana, effective...
FinalCode Opens European Office in London
Sep 01, 2016 10:00 am UTC| Business
LONDON, Sept. 01, 2016 -- FinalCode, Inc., the innovator in persistent file security, today announced the opening of a new regional headquarters to be based in London. Following the continued expansion of FinalCode, the...
Cabot Microelectronics Corporation Appoints Thomas F. Kelly as Vice President, Corporate Development
Sep 01, 2016 10:00 am UTC| Business
Aurora, IL, Sept. 01, 2016 -- Cabot Microelectronics Corporation (Nasdaq: CCMP), the world’s leading supplier of chemical mechanical planarization (CMP) polishing slurries and a growing CMP pad supplier to the...
Sep 01, 2016 09:24 am UTC| Business
东京, Sept. 01, 2016 -- 網頁開發商Widsley Inc.(總部:東京澀谷區,首席執行官:Hirotaka Takahashi,網址為﹕http://widsley.com/)在東京日本橋馬喰町開設一間集酒吧和賓館於一身的「Japanize Guest House Bar」。 ...
Affimed to Present at Upcoming Investor Conferences
Sep 01, 2016 09:00 am UTC| Business
HEIDELBERG, Germany, Sept. 01, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi...